Mckesson (MCK) Net Cash Flow Growth (1y) (2010 - 2026)
Mckesson (MCK) Net Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | -78.03% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 136.31% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 337.50% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -248.15% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 477.50% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 41.83% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 176.76% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -488.71% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -78.03% |
| Dec 31, 2025 | 12.94% |
| Sep 30, 2025 | 567.44% |
| Jun 30, 2025 | -45.25% |
| Mar 31, 2025 | 79.44% |
| Dec 31, 2024 | -122.81% |
| Sep 30, 2024 | 295.45% |
| Jun 30, 2024 | -11.35% |
| Mar 31, 2024 | 37.60% |
| Dec 31, 2023 | -220.47% |
| Sep 30, 2023 | -117.97% |
| Jun 30, 2023 | 1.87% |
| Mar 31, 2023 | 74.93% |
| Dec 31, 2022 | -120.75% |
| Sep 30, 2022 | 6,900.00% |
| Jun 30, 2022 | 46.20% |
| Mar 31, 2022 | -59.18% |
| Dec 31, 2021 | 62.85% |
| Sep 30, 2021 | -102.19% |
| Jun 30, 2021 | -242.35% |